The global market for Insomnia Therapeutics Drugs was estimated to be worth US$ 2921.6 million in 2023 and is forecast to a readjusted size of US$ 3710.3 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030

Insomnia Therapeutics Drugs - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insomnia Therapeutics Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Insomnia Therapeutics Drugs by region & country, by Type, and by Application.

The Insomnia Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Therapeutics Drugs.

Market Segmentation

Scope of Insomnia Therapeutics Drugs - Market Report

Report Metric	Details
Report Name	Insomnia Therapeutics Drugs - Market
Forecasted market size in 2030	US$ 3710.3 million
CAGR	3.4%
Forecasted years	2024 - 2030
Segment by Type:	Benzodiazepines Nonbenzodiazepines Antidepressants Orexin Antagonists Melatonin Antagonists Others
Segment by Application	Prescription Over-the-Counter (OTC)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda Pharmaceutical Company Ltd., Vanda Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sumitomo Dainippon Pharma Co., Ltd, Sanofi, Paratek Pharmaceuticals Inc., Ebb Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Insomnia Therapeutics Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Insomnia Therapeutics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Insomnia Therapeutics Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Insomnia Therapeutics Drugs - Market size in 2030?

Ans: The Insomnia Therapeutics Drugs - Market size in 2030 will be US$ 3710.3 million.

Who are the main players in the Insomnia Therapeutics Drugs - Market report?

Ans: The main players in the Insomnia Therapeutics Drugs - Market are Takeda Pharmaceutical Company Ltd., Vanda Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sumitomo Dainippon Pharma Co., Ltd, Sanofi, Paratek Pharmaceuticals Inc., Ebb Therapeutics

What are the Application segmentation covered in the Insomnia Therapeutics Drugs - Market report?

Ans: The Applications covered in the Insomnia Therapeutics Drugs - Market report are Prescription, Over-the-Counter (OTC)

What are the Type segmentation covered in the Insomnia Therapeutics Drugs - Market report?

Ans: The Types covered in the Insomnia Therapeutics Drugs - Market report are Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists, Others

1 Market Overview

1.1 Insomnia Therapeutics Drugs Product Introduction

1.2 Global Insomnia Therapeutics Drugs Market Size Forecast

1.3 Insomnia Therapeutics Drugs Market Trends & Drivers

1.3.1 Insomnia Therapeutics Drugs Industry Trends

1.3.2 Insomnia Therapeutics Drugs Market Drivers & Opportunity

1.3.3 Insomnia Therapeutics Drugs Market Challenges

1.3.4 Insomnia Therapeutics Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Insomnia Therapeutics Drugs Players Revenue Ranking (2023)

2.2 Global Insomnia Therapeutics Drugs Revenue by Company (2019-2024)

2.3 Key Companies Insomnia Therapeutics Drugs Manufacturing Base Distribution and Headquarters

2.4 Key Companies Insomnia Therapeutics Drugs Product Offered

2.5 Key Companies Time to Begin Mass Production of Insomnia Therapeutics Drugs

2.6 Insomnia Therapeutics Drugs Market Competitive Analysis

2.6.1 Insomnia Therapeutics Drugs Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Insomnia Therapeutics Drugs Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Benzodiazepines

3.1.2 Nonbenzodiazepines

3.1.3 Antidepressants

3.1.4 Orexin Antagonists

3.1.5 Melatonin Antagonists

3.1.6 Others

3.2 Global Insomnia Therapeutics Drugs Sales Value by Type

3.2.1 Global Insomnia Therapeutics Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Insomnia Therapeutics Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Insomnia Therapeutics Drugs Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Prescription

4.1.2 Over-the-Counter (OTC)

4.2 Global Insomnia Therapeutics Drugs Sales Value by Application

4.2.1 Global Insomnia Therapeutics Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Insomnia Therapeutics Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Insomnia Therapeutics Drugs Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Insomnia Therapeutics Drugs Sales Value by Region

5.1.1 Global Insomnia Therapeutics Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Insomnia Therapeutics Drugs Sales Value by Region (2019-2024)

5.1.3 Global Insomnia Therapeutics Drugs Sales Value by Region (2025-2030)

5.1.4 Global Insomnia Therapeutics Drugs Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Insomnia Therapeutics Drugs Sales Value, 2019-2030

5.2.2 North America Insomnia Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Insomnia Therapeutics Drugs Sales Value, 2019-2030

5.3.2 Europe Insomnia Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Insomnia Therapeutics Drugs Sales Value, 2019-2030

5.4.2 Asia Pacific Insomnia Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Insomnia Therapeutics Drugs Sales Value, 2019-2030

5.5.2 South America Insomnia Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Insomnia Therapeutics Drugs Sales Value, 2019-2030

5.6.2 Middle East & Africa Insomnia Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Insomnia Therapeutics Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Insomnia Therapeutics Drugs Sales Value

6.3 United States

6.3.1 United States Insomnia Therapeutics Drugs Sales Value, 2019-2030

6.3.2 United States Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Insomnia Therapeutics Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Insomnia Therapeutics Drugs Sales Value, 2019-2030

6.4.2 Europe Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Insomnia Therapeutics Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Insomnia Therapeutics Drugs Sales Value, 2019-2030

6.5.2 China Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Insomnia Therapeutics Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Insomnia Therapeutics Drugs Sales Value, 2019-2030

6.6.2 Japan Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Insomnia Therapeutics Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Insomnia Therapeutics Drugs Sales Value, 2019-2030

6.7.2 South Korea Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Insomnia Therapeutics Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Insomnia Therapeutics Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Insomnia Therapeutics Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Insomnia Therapeutics Drugs Sales Value, 2019-2030

6.9.2 India Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Insomnia Therapeutics Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Takeda Pharmaceutical Company Ltd.

7.1.1 Takeda Pharmaceutical Company Ltd. Profile

7.1.2 Takeda Pharmaceutical Company Ltd. Main Business

7.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Products, Services and Solutions

7.1.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue (US$ Million) & (2019-2024)

7.1.5 Takeda Pharmaceutical Company Ltd. Recent Developments

7.2 Vanda Pharmaceuticals

7.2.1 Vanda Pharmaceuticals Profile

7.2.2 Vanda Pharmaceuticals Main Business

7.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Products, Services and Solutions

7.2.4 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue (US$ Million) & (2019-2024)

7.2.5 Vanda Pharmaceuticals Recent Developments

7.3 Merck & Co., Inc.

7.3.1 Merck & Co., Inc. Profile

7.3.2 Merck & Co., Inc. Main Business

7.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Products, Services and Solutions

7.3.4 Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue (US$ Million) & (2019-2024)

7.3.5 Pfizer Inc. Recent Developments

7.4 Pfizer Inc.

7.4.1 Pfizer Inc. Profile

7.4.2 Pfizer Inc. Main Business

7.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Products, Services and Solutions

7.4.4 Pfizer Inc. Insomnia Therapeutics Drugs Revenue (US$ Million) & (2019-2024)

7.4.5 Pfizer Inc. Recent Developments

7.5 Teva Pharmaceutical Industries Ltd.

7.5.1 Teva Pharmaceutical Industries Ltd. Profile

7.5.2 Teva Pharmaceutical Industries Ltd. Main Business

7.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Products, Services and Solutions

7.5.4 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue (US$ Million) & (2019-2024)

7.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments

7.6 Mylan N.V.

7.6.1 Mylan N.V. Profile

7.6.2 Mylan N.V. Main Business

7.6.3 Mylan N.V. Insomnia Therapeutics Drugs Products, Services and Solutions

7.6.4 Mylan N.V. Insomnia Therapeutics Drugs Revenue (US$ Million) & (2019-2024)

7.6.5 Mylan N.V. Recent Developments

7.7 Sumitomo Dainippon Pharma Co., Ltd

7.7.1 Sumitomo Dainippon Pharma Co., Ltd Profile

7.7.2 Sumitomo Dainippon Pharma Co., Ltd Main Business

7.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Products, Services and Solutions

7.7.4 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue (US$ Million) & (2019-2024)

7.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments

7.8 Sanofi

7.8.1 Sanofi Profile

7.8.2 Sanofi Main Business

7.8.3 Sanofi Insomnia Therapeutics Drugs Products, Services and Solutions

7.8.4 Sanofi Insomnia Therapeutics Drugs Revenue (US$ Million) & (2019-2024)

7.8.5 Sanofi Recent Developments

7.9 Paratek Pharmaceuticals Inc.

7.9.1 Paratek Pharmaceuticals Inc. Profile

7.9.2 Paratek Pharmaceuticals Inc. Main Business

7.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Products, Services and Solutions

7.9.4 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue (US$ Million) & (2019-2024)

7.9.5 Paratek Pharmaceuticals Inc. Recent Developments

7.10 Ebb Therapeutics

7.10.1 Ebb Therapeutics Profile

7.10.2 Ebb Therapeutics Main Business

7.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Products, Services and Solutions

7.10.4 Ebb Therapeutics Insomnia Therapeutics Drugs Revenue (US$ Million) & (2019-2024)

7.10.5 Ebb Therapeutics Recent Developments

8 Industry Chain Analysis

8.1 Insomnia Therapeutics Drugs Industrial Chain

8.2 Insomnia Therapeutics Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Insomnia Therapeutics Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Insomnia Therapeutics Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceutical Company Ltd

Vanda Pharmaceuticals

Merck& Co. Inc

Pfizer Inc

Teva Pharmaceutical Industries Ltd

Mylan N.V.

Sumitomo Dainippon Pharma Co Ltd

Sanofi

Paratek Pharmaceuticals Inc.

Ebb Therapeutics

List of Tables

Table 1. Insomnia Therapeutics Drugs Market Trends

Table 2. Insomnia Therapeutics Drugs Market Drivers & Opportunity

Table 3. Insomnia Therapeutics Drugs Market Challenges

Table 4. Insomnia Therapeutics Drugs Market Restraints

Table 5. Global Insomnia Therapeutics Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Insomnia Therapeutics Drugs Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Insomnia Therapeutics Drugs Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Insomnia Therapeutics Drugs Product Type

Table 9. Key Companies Time to Begin Mass Production of Insomnia Therapeutics Drugs

Table 10. Global Insomnia Therapeutics Drugs Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Insomnia Therapeutics Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Insomnia Therapeutics Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Insomnia Therapeutics Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Insomnia Therapeutics Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Insomnia Therapeutics Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Insomnia Therapeutics Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Insomnia Therapeutics Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Insomnia Therapeutics Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Insomnia Therapeutics Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Insomnia Therapeutics Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Insomnia Therapeutics Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Insomnia Therapeutics Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Insomnia Therapeutics Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Insomnia Therapeutics Drugs Sales Value by Region (2019-2024) & (%)

Table 27. Global Insomnia Therapeutics Drugs Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Insomnia Therapeutics Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Insomnia Therapeutics Drugs Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Insomnia Therapeutics Drugs Sales Value, (2025-2030) & (US$ Million)

Table 31. Takeda Pharmaceutical Company Ltd. Basic Information List

Table 32. Takeda Pharmaceutical Company Ltd. Description and Business Overview

Table 33. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Products, Services and Solutions

Table 34. Revenue (US$ Million) in Insomnia Therapeutics Drugs Business of Takeda Pharmaceutical Company Ltd. (2019-2024)

Table 35. Takeda Pharmaceutical Company Ltd. Recent Developments

Table 36. Vanda Pharmaceuticals Basic Information List

Table 37. Vanda Pharmaceuticals Description and Business Overview

Table 38. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Products, Services and Solutions

Table 39. Revenue (US$ Million) in Insomnia Therapeutics Drugs Business of Vanda Pharmaceuticals (2019-2024)

Table 40. Vanda Pharmaceuticals Recent Developments

Table 41. Merck & Co., Inc. Basic Information List

Table 42. Merck & Co., Inc. Description and Business Overview

Table 43. Merck & Co., Inc. Insomnia Therapeutics Drugs Products, Services and Solutions

Table 44. Revenue (US$ Million) in Insomnia Therapeutics Drugs Business of Merck & Co., Inc. (2019-2024)

Table 45. Merck & Co., Inc. Recent Developments

Table 46. Pfizer Inc. Basic Information List

Table 47. Pfizer Inc. Description and Business Overview

Table 48. Pfizer Inc. Insomnia Therapeutics Drugs Products, Services and Solutions

Table 49. Revenue (US$ Million) in Insomnia Therapeutics Drugs Business of Pfizer Inc. (2019-2024)

Table 50. Pfizer Inc. Recent Developments

Table 51. Teva Pharmaceutical Industries Ltd. Basic Information List

Table 52. Teva Pharmaceutical Industries Ltd. Description and Business Overview

Table 53. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Products, Services and Solutions

Table 54. Revenue (US$ Million) in Insomnia Therapeutics Drugs Business of Teva Pharmaceutical Industries Ltd. (2019-2024)

Table 55. Teva Pharmaceutical Industries Ltd. Recent Developments

Table 56. Mylan N.V. Basic Information List

Table 57. Mylan N.V. Description and Business Overview

Table 58. Mylan N.V. Insomnia Therapeutics Drugs Products, Services and Solutions

Table 59. Revenue (US$ Million) in Insomnia Therapeutics Drugs Business of Mylan N.V. (2019-2024)

Table 60. Mylan N.V. Recent Developments

Table 61. Sumitomo Dainippon Pharma Co., Ltd Basic Information List

Table 62. Sumitomo Dainippon Pharma Co., Ltd Description and Business Overview

Table 63. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Products, Services and Solutions

Table 64. Revenue (US$ Million) in Insomnia Therapeutics Drugs Business of Sumitomo Dainippon Pharma Co., Ltd (2019-2024)

Table 65. Sumitomo Dainippon Pharma Co., Ltd Recent Developments

Table 66. Sanofi Basic Information List

Table 67. Sanofi Description and Business Overview

Table 68. Sanofi Insomnia Therapeutics Drugs Products, Services and Solutions

Table 69. Revenue (US$ Million) in Insomnia Therapeutics Drugs Business of Sanofi (2019-2024)

Table 70. Sanofi Recent Developments

Table 71. Paratek Pharmaceuticals Inc. Basic Information List

Table 72. Paratek Pharmaceuticals Inc. Description and Business Overview

Table 73. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Products, Services and Solutions

Table 74. Revenue (US$ Million) in Insomnia Therapeutics Drugs Business of Paratek Pharmaceuticals Inc. (2019-2024)

Table 75. Paratek Pharmaceuticals Inc. Recent Developments

Table 76. Ebb Therapeutics Basic Information List

Table 77. Ebb Therapeutics Description and Business Overview

Table 78. Ebb Therapeutics Insomnia Therapeutics Drugs Products, Services and Solutions

Table 79. Revenue (US$ Million) in Insomnia Therapeutics Drugs Business of Ebb Therapeutics (2019-2024)

Table 80. Ebb Therapeutics Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Insomnia Therapeutics Drugs Downstream Customers

Table 84. Insomnia Therapeutics Drugs Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Insomnia Therapeutics Drugs Product Picture

Figure 2. Global Insomnia Therapeutics Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Insomnia Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Insomnia Therapeutics Drugs Report Years Considered

Figure 5. Global Insomnia Therapeutics Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Insomnia Therapeutics Drugs Revenue in 2023

Figure 7. Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Benzodiazepines Picture

Figure 9. Nonbenzodiazepines Picture

Figure 10. Antidepressants Picture

Figure 11. Orexin Antagonists Picture

Figure 12. Melatonin Antagonists Picture

Figure 13. Others Picture

Figure 14. Global Insomnia Therapeutics Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Insomnia Therapeutics Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 16. Product Picture of Prescription

Figure 17. Product Picture of Over-the-Counter (OTC)

Figure 18. Global Insomnia Therapeutics Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global Insomnia Therapeutics Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America Insomnia Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)

Figure 21. North America Insomnia Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe Insomnia Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe Insomnia Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific Insomnia Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific Insomnia Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

Figure 26. South America Insomnia Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)

Figure 27. South America Insomnia Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa Insomnia Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa Insomnia Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions Insomnia Therapeutics Drugs Sales Value (%), (2019-2030)

Figure 31. United States Insomnia Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 33. United States Insomnia Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe Insomnia Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe Insomnia Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030

Figure 37. China Insomnia Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 38. China Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 39. China Insomnia Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan Insomnia Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan Insomnia Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea Insomnia Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea Insomnia Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia Insomnia Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia Insomnia Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030

Figure 49. India Insomnia Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 50. India Insomnia Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 51. India Insomnia Therapeutics Drugs Sales Value by Application (%), 2023 VS 2030

Figure 52. Insomnia Therapeutics Drugs Industrial Chain

Figure 53. Insomnia Therapeutics Drugs Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Insomnia Pharmacological Treatment Market Research Report 2025

Global Sleeping Pills Market Research Report 2025

Global Sleeping Pills Prescription Drugs Market Research Report 2025

Antidepressants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Infectives Market Research Report 2025

Prescription Sleeping Pills Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Depression MDD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Still s Disease Treatment Market Research Report 2025

Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical Asset Managements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global TNF IL Cytokines Market Insights Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-37W13711

Wed Jun 04 00:00:00 UTC 2025

Add to Cart

Global Inhalation & Nasal Spray Generic Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-2R327

Wed Jun 04 00:00:00 UTC 2025

Add to Cart

Global PEG-G-CSF Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32L16141

Wed Jun 04 00:00:00 UTC 2025

Add to Cart

Global Topical Anesthetic Creams Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12R16466

Tue Jun 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Insomnia Therapeutics Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-7E13506

Insomnia Therapeutics Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Insomnia Therapeutics Drugs - Market Size

Insomnia Therapeutics Drugs - Market

Report Scope

Scope of Insomnia Therapeutics Drugs - Market Report

Chapter Outline

FAQ for this report

What is the Insomnia Therapeutics Drugs - Market size in 2030?

Who are the main players in the Insomnia Therapeutics Drugs - Market report?

What are the Application segmentation covered in the Insomnia Therapeutics Drugs - Market report?

What are the Type segmentation covered in the Insomnia Therapeutics Drugs - Market report?

FEATURED COMPANIES

RELATED REPORTS